Global RNA Oligonucleotide Synthesis Service Market 2023 by Company, Regions, Type and Application, Forecast to 2029

1 Market Overview

• 1.1 Product Overview and Scope of RNA Oligonucleotide Synthesis Service
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Classification of RNA Oligonucleotide Synthesis Service by Type
  • 1.3.1 Overview: Global RNA Oligonucleotide Synthesis Service Market Size by Type: 2018 Versus 2022 Versus 2029
  • 1.3.2 Global RNA Oligonucleotide Synthesis Service Consumption Value Market Share by Type in 2022
  • 1.3.3 Standard Oligonucleotides
  • 1.3.4 Micro-Oligonucleotides
  • 1.3.5 Large-scale Oligonucleotides
  • 1.3.6 Degenerate Primers
  • 1.3.7 Long Oligos Synthesis
• 1.4 Global RNA Oligonucleotide Synthesis Service Market by Application
  • 1.4.1 Overview: Global RNA Oligonucleotide Synthesis Service Market Size by Application: 2018 Versus 2022 Versus 2029
  • 1.4.2 Commercial
  • 1.4.3 Academic Research
• 1.5 Global RNA Oligonucleotide Synthesis Service Market Size & Forecast
• 1.6 Global RNA Oligonucleotide Synthesis Service Market Size and Forecast by Region
  • 1.6.1 Global RNA Oligonucleotide Synthesis Service Market Size by Region: 2018 VS 2022 VS 2029
  • 1.6.2 Global RNA Oligonucleotide Synthesis Service Market Size by Region, (2018-2029)
  • 1.6.3 North America RNA Oligonucleotide Synthesis Service Market Size and Prospect (2018-2029)
  • 1.6.4 Europe RNA Oligonucleotide Synthesis Service Market Size and Prospect (2018-2029)
  • 1.6.5 Asia-Pacific RNA Oligonucleotide Synthesis Service Market Size and Prospect (2018-2029)
  • 1.6.6 South America RNA Oligonucleotide Synthesis Service Market Size and Prospect (2018-2029)
  • 1.6.7 Middle East and Africa RNA Oligonucleotide Synthesis Service Market Size and Prospect (2018-2029)

2 Company Profiles

• 2.1 GenScript
  • 2.1.1 GenScript Details
  • 2.1.2 GenScript Major Business
  • 2.1.3 GenScript RNA Oligonucleotide Synthesis Service Product and Solutions
  • 2.1.4 GenScript RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
  • 2.1.5 GenScript Recent Developments and Future Plans
• 2.2 OriGene
  • 2.2.1 OriGene Details
  • 2.2.2 OriGene Major Business
  • 2.2.3 OriGene RNA Oligonucleotide Synthesis Service Product and Solutions
  • 2.2.4 OriGene RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
  • 2.2.5 OriGene Recent Developments and Future Plans
• 2.3 BBI
  • 2.3.1 BBI Details
  • 2.3.2 BBI Major Business
  • 2.3.3 BBI RNA Oligonucleotide Synthesis Service Product and Solutions
  • 2.3.4 BBI RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
  • 2.3.5 BBI Recent Developments and Future Plans
• 2.4 Genewiz
  • 2.4.1 Genewiz Details
  • 2.4.2 Genewiz Major Business
  • 2.4.3 Genewiz RNA Oligonucleotide Synthesis Service Product and Solutions
  • 2.4.4 Genewiz RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
  • 2.4.5 Genewiz Recent Developments and Future Plans
• 2.5 Eurofins Genomics
  • 2.5.1 Eurofins Genomics Details
  • 2.5.2 Eurofins Genomics Major Business
  • 2.5.3 Eurofins Genomics RNA Oligonucleotide Synthesis Service Product and Solutions
  • 2.5.4 Eurofins Genomics RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
  • 2.5.5 Eurofins Genomics Recent Developments and Future Plans
• 2.6 Gene Oracle
  • 2.6.1 Gene Oracle Details
  • 2.6.2 Gene Oracle Major Business
  • 2.6.3 Gene Oracle RNA Oligonucleotide Synthesis Service Product and Solutions
  • 2.6.4 Gene Oracle RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
  • 2.6.5 Gene Oracle Recent Developments and Future Plans
• 2.7 SBS Genetech
  • 2.7.1 SBS Genetech Details
  • 2.7.2 SBS Genetech Major Business
  • 2.7.3 SBS Genetech RNA Oligonucleotide Synthesis Service Product and Solutions
  • 2.7.4 SBS Genetech RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
  • 2.7.5 SBS Genetech Recent Developments and Future Plans
• 2.8 Creative Biolabs
  • 2.8.1 Creative Biolabs Details
  • 2.8.2 Creative Biolabs Major Business
  • 2.8.3 Creative Biolabs RNA Oligonucleotide Synthesis Service Product and Solutions
  • 2.8.4 Creative Biolabs RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
  • 2.8.5 Creative Biolabs Recent Developments and Future Plans
• 2.9 Bio Basic
  • 2.9.1 Bio Basic Details
  • 2.9.2 Bio Basic Major Business
  • 2.9.3 Bio Basic RNA Oligonucleotide Synthesis Service Product and Solutions
  • 2.9.4 Bio Basic RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
  • 2.9.5 Bio Basic Recent Developments and Future Plans
• 2.10 Kaneka Eurogentec SA
  • 2.10.1 Kaneka Eurogentec SA Details
  • 2.10.2 Kaneka Eurogentec SA Major Business
  • 2.10.3 Kaneka Eurogentec SA RNA Oligonucleotide Synthesis Service Product and Solutions
  • 2.10.4 Kaneka Eurogentec SA RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
  • 2.10.5 Kaneka Eurogentec SA Recent Developments and Future Plans
• 2.11 AltaBioscience
  • 2.11.1 AltaBioscience Details
  • 2.11.2 AltaBioscience Major Business
  • 2.11.3 AltaBioscience RNA Oligonucleotide Synthesis Service Product and Solutions
  • 2.11.4 AltaBioscience RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
  • 2.11.5 AltaBioscience Recent Developments and Future Plans
• 2.12 Synbio Technologies
  • 2.12.1 Synbio Technologies Details
  • 2.12.2 Synbio Technologies Major Business
  • 2.12.3 Synbio Technologies RNA Oligonucleotide Synthesis Service Product and Solutions
  • 2.12.4 Synbio Technologies RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
  • 2.12.5 Synbio Technologies Recent Developments and Future Plans
• 2.13 TriLink
  • 2.13.1 TriLink Details
  • 2.13.2 TriLink Major Business
  • 2.13.3 TriLink RNA Oligonucleotide Synthesis Service Product and Solutions
  • 2.13.4 TriLink RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
  • 2.13.5 TriLink Recent Developments and Future Plans
• 2.14 Azenta Life Science
  • 2.14.1 Azenta Life Science Details
  • 2.14.2 Azenta Life Science Major Business
  • 2.14.3 Azenta Life Science RNA Oligonucleotide Synthesis Service Product and Solutions
  • 2.14.4 Azenta Life Science RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
  • 2.14.5 Azenta Life Science Recent Developments and Future Plans
• 2.15 KareBay Biochem
  • 2.15.1 KareBay Biochem Details
  • 2.15.2 KareBay Biochem Major Business
  • 2.15.3 KareBay Biochem RNA Oligonucleotide Synthesis Service Product and Solutions
  • 2.15.4 KareBay Biochem RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
  • 2.15.5 KareBay Biochem Recent Developments and Future Plans
• 2.16 Creative Biogene
  • 2.16.1 Creative Biogene Details
  • 2.16.2 Creative Biogene Major Business
  • 2.16.3 Creative Biogene RNA Oligonucleotide Synthesis Service Product and Solutions
  • 2.16.4 Creative Biogene RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
  • 2.16.5 Creative Biogene Recent Developments and Future Plans
• 2.17 Generi Biotech
  • 2.17.1 Generi Biotech Details
  • 2.17.2 Generi Biotech Major Business
  • 2.17.3 Generi Biotech RNA Oligonucleotide Synthesis Service Product and Solutions
  • 2.17.4 Generi Biotech RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
  • 2.17.5 Generi Biotech Recent Developments and Future Plans
• 2.18 Primetech
  • 2.18.1 Primetech Details
  • 2.18.2 Primetech Major Business
  • 2.18.3 Primetech RNA Oligonucleotide Synthesis Service Product and Solutions
  • 2.18.4 Primetech RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
  • 2.18.5 Primetech Recent Developments and Future Plans
• 2.19 General Biosystems
  • 2.19.1 General Biosystems Details
  • 2.19.2 General Biosystems Major Business
  • 2.19.3 General Biosystems RNA Oligonucleotide Synthesis Service Product and Solutions
  • 2.19.4 General Biosystems RNA Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
  • 2.19.5 General Biosystems Recent Developments and Future Plans

3 Market Competition, by Players

• 3.1 Global RNA Oligonucleotide Synthesis Service Revenue and Share by Players (2018-2023)
• 3.2 Market Share Analysis (2022)
  • 3.2.1 Market Share of RNA Oligonucleotide Synthesis Service by Company Revenue
  • 3.2.2 Top 3 RNA Oligonucleotide Synthesis Service Players Market Share in 2022
  • 3.2.3 Top 6 RNA Oligonucleotide Synthesis Service Players Market Share in 2022
• 3.3 RNA Oligonucleotide Synthesis Service Market: Overall Company Footprint Analysis
  • 3.3.1 RNA Oligonucleotide Synthesis Service Market: Region Footprint
  • 3.3.2 RNA Oligonucleotide Synthesis Service Market: Company Product Type Footprint
  • 3.3.3 RNA Oligonucleotide Synthesis Service Market: Company Product Application Footprint
• 3.4 New Market Entrants and Barriers to Market Entry
• 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

• 4.1 Global RNA Oligonucleotide Synthesis Service Consumption Value and Market Share by Type (2018-2023)
• 4.2 Global RNA Oligonucleotide Synthesis Service Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

• 5.1 Global RNA Oligonucleotide Synthesis Service Consumption Value Market Share by Application (2018-2023)
• 5.2 Global RNA Oligonucleotide Synthesis Service Market Forecast by Application (2024-2029)

6 North America

• 6.1 North America RNA Oligonucleotide Synthesis Service Consumption Value by Type (2018-2029)
• 6.2 North America RNA Oligonucleotide Synthesis Service Consumption Value by Application (2018-2029)
• 6.3 North America RNA Oligonucleotide Synthesis Service Market Size by Country
  • 6.3.1 North America RNA Oligonucleotide Synthesis Service Consumption Value by Country (2018-2029)
  • 6.3.2 United States RNA Oligonucleotide Synthesis Service Market Size and Forecast (2018-2029)
  • 6.3.3 Canada RNA Oligonucleotide Synthesis Service Market Size and Forecast (2018-2029)
  • 6.3.4 Mexico RNA Oligonucleotide Synthesis Service Market Size and Forecast (2018-2029)

7 Europe

• 7.1 Europe RNA Oligonucleotide Synthesis Service Consumption Value by Type (2018-2029)
• 7.2 Europe RNA Oligonucleotide Synthesis Service Consumption Value by Application (2018-2029)
• 7.3 Europe RNA Oligonucleotide Synthesis Service Market Size by Country
  • 7.3.1 Europe RNA Oligonucleotide Synthesis Service Consumption Value by Country (2018-2029)
  • 7.3.2 Germany RNA Oligonucleotide Synthesis Service Market Size and Forecast (2018-2029)
  • 7.3.3 France RNA Oligonucleotide Synthesis Service Market Size and Forecast (2018-2029)
  • 7.3.4 United Kingdom RNA Oligonucleotide Synthesis Service Market Size and Forecast (2018-2029)
  • 7.3.5 Russia RNA Oligonucleotide Synthesis Service Market Size and Forecast (2018-2029)
  • 7.3.6 Italy RNA Oligonucleotide Synthesis Service Market Size and Forecast (2018-2029)

8 Asia-Pacific

• 8.1 Asia-Pacific RNA Oligonucleotide Synthesis Service Consumption Value by Type (2018-2029)
• 8.2 Asia-Pacific RNA Oligonucleotide Synthesis Service Consumption Value by Application (2018-2029)
• 8.3 Asia-Pacific RNA Oligonucleotide Synthesis Service Market Size by Region
  • 8.3.1 Asia-Pacific RNA Oligonucleotide Synthesis Service Consumption Value by Region (2018-2029)
  • 8.3.2 China RNA Oligonucleotide Synthesis Service Market Size and Forecast (2018-2029)
  • 8.3.3 Japan RNA Oligonucleotide Synthesis Service Market Size and Forecast (2018-2029)
  • 8.3.4 South Korea RNA Oligonucleotide Synthesis Service Market Size and Forecast (2018-2029)
  • 8.3.5 India RNA Oligonucleotide Synthesis Service Market Size and Forecast (2018-2029)
  • 8.3.6 Southeast Asia RNA Oligonucleotide Synthesis Service Market Size and Forecast (2018-2029)
  • 8.3.7 Australia RNA Oligonucleotide Synthesis Service Market Size and Forecast (2018-2029)

9 South America

• 9.1 South America RNA Oligonucleotide Synthesis Service Consumption Value by Type (2018-2029)
• 9.2 South America RNA Oligonucleotide Synthesis Service Consumption Value by Application (2018-2029)
• 9.3 South America RNA Oligonucleotide Synthesis Service Market Size by Country
  • 9.3.1 South America RNA Oligonucleotide Synthesis Service Consumption Value by Country (2018-2029)
  • 9.3.2 Brazil RNA Oligonucleotide Synthesis Service Market Size and Forecast (2018-2029)
  • 9.3.3 Argentina RNA Oligonucleotide Synthesis Service Market Size and Forecast (2018-2029)

10 Middle East & Africa

• 10.1 Middle East & Africa RNA Oligonucleotide Synthesis Service Consumption Value by Type (2018-2029)
• 10.2 Middle East & Africa RNA Oligonucleotide Synthesis Service Consumption Value by Application (2018-2029)
• 10.3 Middle East & Africa RNA Oligonucleotide Synthesis Service Market Size by Country
  • 10.3.1 Middle East & Africa RNA Oligonucleotide Synthesis Service Consumption Value by Country (2018-2029)
  • 10.3.2 Turkey RNA Oligonucleotide Synthesis Service Market Size and Forecast (2018-2029)
  • 10.3.3 Saudi Arabia RNA Oligonucleotide Synthesis Service Market Size and Forecast (2018-2029)
  • 10.3.4 UAE RNA Oligonucleotide Synthesis Service Market Size and Forecast (2018-2029)

11 Market Dynamics

• 11.1 RNA Oligonucleotide Synthesis Service Market Drivers
• 11.2 RNA Oligonucleotide Synthesis Service Market Restraints
• 11.3 RNA Oligonucleotide Synthesis Service Trends Analysis
• 11.4 Porters Five Forces Analysis
  • 11.4.1 Threat of New Entrants
  • 11.4.2 Bargaining Power of Suppliers
  • 11.4.3 Bargaining Power of Buyers
  • 11.4.4 Threat of Substitutes
  • 11.4.5 Competitive Rivalry
• 11.5 Influence of COVID-19 and Russia-Ukraine War
  • 11.5.1 Influence of COVID-19
  • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

• 12.1 RNA Oligonucleotide Synthesis Service Industry Chain
• 12.2 RNA Oligonucleotide Synthesis Service Upstream Analysis
• 12.3 RNA Oligonucleotide Synthesis Service Midstream Analysis
• 12.4 RNA Oligonucleotide Synthesis Service Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Research Process and Data Source